Drug Profile
Moxifloxacin ophthalmic solution - Alcon
Alternative Names: AL-15469A; BAY-12-8039; BAY-X-8843; Kanavig; Moxafloxacin hydrochloride; Moxeza; Moxifloxacin hydrochloride ophthalmic solution - Alcon; Moxifloxacin hydrochloride otic solution - Alcon; Moxivig; Vegamox; Vigamox; VigamoxiLatest Information Update: 04 Oct 2023
Price :
$50
*
At a glance
- Originator Bayer
- Developer Alcon
- Class Antibacterials; Azabicyclo compounds; Cyclopropanes; Fluoroquinolones; Piperidines; Pyrrolidines; Small molecules
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Infectious conjunctivitis; Postoperative infections
- Discontinued Otitis externa